For the health of
all the world's people.
We are taking on the challenge of
"Unmet Medical Needs".
News Release
Alfresa Holdings
- ■2026/02/12 Notice Regarding the Release of neffy® 1 mg and neffy® 2 mg as Emergency Supportive Therapy to Suppress Anaphylaxis
- ■2026/02/10 Notice Regarding the Recording of Extraordinary Profit(Gain on Sales of Investment Securities)
- ■2026/02/10 Consolidated Financial Results for the Nine Months Ended December 31, 2025
- ■2026/02/10 Financial Results Summary for the Third Quarter Ended December 31, 2025
- ■2026/02/05 Notice Regarding Alliance Between Alfresa Corporation and Choraku Choju K.K. to Eliminate Social Isolation and Extend Healthy Life Expectancies
